GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Solara Active Pharma Sciences SOLARA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

648.05

+2.26%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Forecasts

Analyst averages for the fiscal years ahead

FY2027
Revenue₹17.95bn
Revenue, highest₹17.95bn
Revenue, lowest₹17.95bn
Earnings per share31.40
Earnings per share, highest31.40
Earnings per share, lowest31.40
Analysts1

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q4 2023
Forecast14.7514.75-2.15
Reported5.923.52-54.47
Difference-59.9%-76.1%-2432.9%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -0.6%.

Model fair value

518.77

From earnings 518.77, from revenue 541.01.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.